BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

Clinical trial NCT00835770 · COMPLETED

Trial details

NCT number: NCT00835770
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2009-02-03
Primary completion: 2019-11-08
Enrollment: 1736

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.